Ingredient or product comparison
Best GHK-Cu Dosage Scar Reduction 2026: Treatment Comparison
Before committing to a GHK-Cu protocol, compare it against other evidence-based scar treatments to understand where it fits in the hierarchy of clinical efficacy. GHK-Cu (systemic injection) Activates MMP-2/MMP-9 for collagen remodeling; inhibits TGF-β1 1–3mg
This source-based comparison does not add ratings or recommend a winner.
- Before committing to a GHK-Cu protocol, compare it against other evidence-based scar treatments to understand where it fits in the hierarchy of clinical efficacy.
- GHK-Cu (systemic injection)
- Activates MMP-2/MMP-9 for collagen remodeling; inhibits TGF-β1
- 1–3mg subcutaneous daily, 12–24 weeks
- Moderate (Phase 2 trials, observational studies)
- Atrophic scars, early hypertrophic scars
- First-line for superficial scarring; slower than ablative options but avoids downtime
- GHK-Cu (topical 2–5%)
- Same mechanism; limited to upper dermis penetration
- Twice daily application, 12–24 weeks
- Moderate (split-face trials, case series)
- Acne scars, superficial surgical scars, hyperpigmentation
- Requires consistency; works best with microneedling for deeper penetration
- Microneedling + GHK-Cu
- Creates microchannels for peptide penetration; triggers wound repair cascade
- 0.5–1.5mm depth monthly, GHK-Cu applied immediately post-procedure
- High (multiple RCTs)
- Moderate atrophic scars, ice-pick scars
- Gold standard for acne scarring; combine with GHK-Cu for superior collagen organization
- Fractional CO2 Laser
- Ablates scar tissue; induces controlled wound healing
- 1–3 sessions spaced 4–6 weeks
- High (systematic reviews, meta-analyses)
- Deep atrophic scars, severe texture irregularities
- Fastest visible results but requires 7–14 days downtime per session
- Silicone Sheeting
- Hydrates stratum corneum; reduces TGF-β1 expression
- 12+ hours daily, 8–12 weeks
- High (Cochrane review)
- Hypertrophic scars, keloids (prevention)
- Effective for raised scars; no effect on atrophic scars or pigmentation
- Intralesional Corticosteroids
- Suppresses fibroblast proliferation and collagen synthesis
- 10–40mg/mL triamcinolone every 4–6 weeks
- High (standard of care for keloids)
- Keloids, resistant hypertrophic scars
- First-line for keloid flattening; risk of atrophy with overuse